Immunophenotyping of leucocytes (x103cells/mm3) | |||||||
---|---|---|---|---|---|---|---|
Age at diagnosis Y: years/m: months | Lymphocytes CD45+ | CD3+ | CD3+ CD4+ | CD3+ CD8+ | CD19+ | HLA DR | |
1 | 10 y | 2.9 (1.90–3.70) | 2.6 (1.20–2.60) | 0.6 (0.65–1.50) | 1.9 (0.37–1.10) | 0.2 (0.27–0.86) | 0 |
2 | 2 y 6 m | 4.6 (2.30–5.40) | 2.4 (1.40–3.70) | 0.5 (0.70–2.20) | 1.5 (0.49–1.30) | 1.2 (0.39–1.40) | 0 |
3 | 4 y | 6.2 (2.30–5.40) | 4.8 (1.40–3.70) | 0.3 (0.70–2.20) | 2.9 (0.49–1.30) | 0.2 (0.39–1.40) | 0 |
4 | 2 m | 3.3 (3.40–7.60) | 1.6 (2.50–5.50) | 0.4 (1.60–4.00) | 1.2 (0.56–1.70) | 0.7 (0.30–2.00) | 0 |
5 | 1 y 10 m | 1.2 (3.60–8.90) | 0.3 (2.10–6.20) | 0.2 (1.30–3.40) | 0.1 (0.62–2.00) | 0.4 (0.72–2.60) | 0 |
6 | 4 y | 1.5 (2.30–5.40) | 0.7 (1.40–3.70) | 0.3 (0.70–2.20) | 0.3 (0.49–1.30) | 0.3 (0.39–1.40) | 0 |
7 | 2 y 3 m | 4 (2.30–5.40) | 2.5 (1.40–3.70) | 1.4 (0.70–2.20) | 0.6 (0.49–1.30) | 1.1 (0.39–1.40) | 0 |
8 | 4 y | 3.7 (2.30–5.40) | 2.3 (1.40–3.70) | 3.3 (0.70–2.20) | 1.1 (0.49–1.30) | 0.4 (0.39–1.40) | 0 |
9 | 2 y | 1.2 (2.30–5.40) | 0.8 (1.40–3.70) | 0.2 (0.70–2.20) | 0.5 (0.49–1.30) | 0.07 (0.39–1.40) | 0 |
10 | 6 y | 3.2 (1.90–3.70) | 2.4 (1.20–2.60) | 0.3 (0.65–1.50) | 1.5 (0.37–1.10) | 0.4 (0.27–0.86) | 0 |
11 | 4 y | 3.5 (2.30–5.40) | 1.9 (1.40–3.70) | 0.15 (0.70–2.20) | 1 (0.49–1.30) | 0.18 (0.39–1.40) | 0 |